Nine in Ten Surveyed Adults Believe Rx Prices “Much Higher” Or “Somewhat Higher” Than Reasonable A new Gallup survey demonstrates the rising toll of out-of-control prescription drug prices on American patients and families. According to the survey, nearly 23 percent of Americans, approaching 58 million U.S. adults, say they have been unable to afford…
Drug Makers Cry ‘False Narrative’ Over Latest Repot Highlighting Toll of the Industry’s Egregious Pricing Practices Last week, the Centers for Medicare & Medicaid Services (CMS) released a…
Q3 Earnings: Big Pharma Keeps The Good Times Rolling While Hiking Prices Top Brand Name Drug Makers Best Earnings Forecasts While Evading Accountability And that’s a wrap! Three weeks of earnings…
Solutions to Reform Medicare Part D, Increase Competition and Boost Transparency Have Broad Bipartisan Support, Should Be Swiftly Passed THE CRISIS OF RISING PRESCRIPTION DRUG PRICES The…
Brand Name Drug Giant Completes Sweep of Big Pharma Companies Who Beat Expectations After Hiking Prices Earnings reports for the third quarter of the year provide the latest evidence that Big Pharma…
Good Times Rolling for Brand Name Drug Makers, Two More Top Earnings Forecasts After Increasing Prices Two more brand name giants – Bristol-Myers Squibb and Sanofi – topped earnings expectations…
Big Pharma’s Earnings Keep Rising Off of Price Hikes To no one’s surprise, two more brand name drug manufacturers, GlaxoSmithKline (GSK) and Amgen both topped earnings expectations for the third…
Two More Big Pharma Giants Beat Q3 Forecasts After Hiking Prices On Cancer And Arthritis Drugs Kicking off the final week of Q3 earnings reports, two more brand name giants – Merck and Pfizer –…
Pharmaceutical Giant Beats Q3 Profit Forecasts After Hiking Prices on Drugs Used to Treat Diabetes and Cancer Yesterday, Eli Lilly joined fellow Big Pharma giants Johnson & Johnson, Roche and…
Another Brand Name Drug Maker Beats Expectations After Raising Prices Rounding out this week’s reporting on third quarter earnings, Big Pharma giant AstraZeneca joined four other brand name giants…